NCT07699523
The Effects of Midazolam, Dexmedetomidine, and Esketamine on Bispectral Index and Raw Electroencephalogram in Patients Under Propofol-Remifentanil Baseline Anesthesia
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Recruitment opened Show 4 more changesShow less
- Eligibility criteria expanded, about 11 words
- Study sites: 1 to 2
- Start date changed from estimate of Jun 30, 2026 to Jul 14, 2026
- Secondary endpoints: details revised at 1 of 7 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (7)
Show 2 moreShow less
Arms and interventions
Participants receive standardized propofol-remifentanil total intravenous anesthesia without administration of the study adjunct anesthetic drug.
Participants receive standardized propofol-remifentanil total intravenous anesthesia plus midazolam according to the study protocol.
Participants receive standardized propofol-remifentanil total intravenous anesthesia plus dexmedetomidine according to the study protocol.
Participants receive standardized propofol-remifentanil total intravenous anesthesia plus esketamine according to the study protocol.
Drugs: Midazolam, Dexmedetomidine, Esketamine, Propofol, Remifentanil
Sites
2 sites in 1 country